June 28, 2011
|
Human Capital Blog
Post
To examine the extent of medical students’ relationships with industry – as well as the impact of these interactions – my colleagues, Kirsten Austad and Jerry Avorn, M.D., and I conducted a systematic review of the literature, examining all publishe ...
November 12, 2009
|
Journal Article
Direct-to-consumer advertising (DTCA) of prescription drugs has remained controversial since regulations were liberalized by the FDA in 1997. This study reviewed empirical evidence addressing the claims made in the policy debate for and against DTCA.
January 2, 2008
|
Story
Health & Society Scholar Dominick L. Frosch, PhD, a clinical psychologist, collaborated with colleagues at the University of Pennsylvania to determine that DTC commercials have limited educational value.
April 1, 2008
|
Journal Article
Current FDA, FTC, and FCC guidelines governing product placements in entertainment are extremely vague. Although the pharmaceutical industry has not used this marketing tool heavily, the possibility for abuse of it by the industry remains real. Stricter guidelines should be developed.
August 19, 2008
|
Journal Article
Seeding trials are clinical studies conducted by pharmaceutical companies designed to seem as if they answer a scientific question, but primarily fulfill marketing objectives they have not been described in detail.
May 1, 2013
|
Journal Article
At stake in the May 2013 publication of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), are billions of dollars in insurance payments and government resources.
August 1, 2006
|
Journal Article
This research analyzes a unique data set the authors collected concerning print and broadcast media attention in order to answer two questions: How is social burden of disease related to media attention? And, how do organized interest groups affect ...
September 1, 2007
|
Journal Article
Direct-to-consumer (DTC) prescription drug advertisements for HIV antiretrovirals are controversial and have been criticized in the past for including deceptive images and underplaying HIV drug limitations. The authors sought to describe the state o ...